Updated:
Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky
Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky (PPGNHAIK) formed in 1948 and operates today as a 501(c)(3) nonprofit covering Alaska,...
Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky
Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky (PPGNHAIK) formed in 1948 and operates today as a 501(c)(3) nonprofit covering Alaska, Hawai'i, Idaho, Indiana, Kentucky, and western Washington. CEO Rebecca Gibron, CFO Bill Dean, and Chief Legal Counsel Richard Muniz manage an organization that blends clinical service delivery with a dedicated endowment — a capital base that sits inside a larger operating budget dominated by patient fees, federal Title X grants, and philanthropy. The structure mirrors that of other large healthcare-affiliated nonprofits: a long-term investment pool that buffers against political and operational volatility. PPGNHAIK's investment portfolio does not disclose its size or allocation publicly, but Altss estimates the endowment at below $50 million. The fund's strategy spans buyout, early-stage, growth, and late-stage exposure — a wider-than-typical mandate for an endowment of this scale, suggesting a manager-of-managers or commingled-fund approach rather than a direct-investment program. The national Planned Parenthood Federation of America functions as both parent and business partner, and the affiliate's legal and advocacy work often co-invests with the ACLU in reproductive rights litigation. Donor relationships include the Peierls Foundation and BNY Mellon Charitable Gift Fund, giving the endowment visibility into the broader progressive philanthropic capital ecosystem. Gibron also serves as board chair of Kaleido Health and sits on the board of the Labs Services Cooperative, connecting the affiliate to fringe healthcare ventures and laboratory networks. The organization's physical plant includes an administrative headquarters in Seattle's Central District and health centers in Anchorage, Juneau, Fairbanks, Meridian, Idaho, and Lexington, Kentucky, among others. In 2026, the Peierls Foundation provided a $107,500 grant and in 2025, BNY Mellon Charitable Gift Fund granted $261,000 — operational gifts that augment the investable asset base without flowing directly into the endowment pool. The structural differentiator is the affiliate's dual posture as a healthcare operating company and an activist legal entity. Unlike a pure grantmaking foundation, PPGNHAIK runs brick-and-mortar clinics subject to state-level regulatory pressure while simultaneously litigating against those same state actors. Its endowment must therefore serve both as a rainy-day fund for clinic operations and as a backstop for legal campaigns — a liquidity demand profile that distinguishes it from a typical private foundation or university endowment of comparable size.
General information
Firm type
Endowment / Foundation
Year founded
1948
Location
Region
North America
Country
United States
City
Seattle
Corporate office
Seattle, WA, United States
Principals
Rebecca Gibron
CEO
Bill Dean
CFO
Richard Muniz
Chief Legal Counsel
Sector focus
Frequently asked questions
Who runs investment decisions at PPGNHAIK?
The organization does not publicly name a chief investment officer or dedicated investment committee. CEO Rebecca Gibron and CFO Bill Dean are the senior-most financial officers, and the endowment's strategy — spanning buyout, growth, and late-stage exposure — is executed through an undisclosed mix of external managers and commingled funds.
How is PPGNHAIK's endowment structured relative to the national Planned Parenthood federation?
PPGNHAIK is a separately incorporated 501(c)(3) affiliate of the Planned Parenthood Federation of America. It maintains its own balance sheet and investment portfolio, distinct from the national office and from other affiliates. The Federation acts as a parent organization and business partner but does not directly control the affiliate's endowment allocation decisions.
Does PPGNHAIK make direct investments or fund commitments?
The endowment's strategy tags include buyout, early-stage, expansion, and late-stage exposure. Given the sub-$50 million estimated portfolio size, direct control investments are unlikely at meaningful scale. The likely implementation is through fund commitments and possibly a small sleeve of co-investments alongside managers with whom the organization has donor or board relationships.
How does the advocacy and litigation work influence the investment posture?
PPGNHAIK's frequent co-litigation with the ACLU and its operation of Planned Parenthood Alliance Advocates as a separate advocacy arm create a unique liquidity pressure. The endowment must be available to fund both clinical operations during politically-driven revenue disruptions and legal campaigns that can require rapid capital deployment — a dual mandate that likely skews the portfolio toward more liquid allocations than a pure endowment model.
What is Kaleido Health and how is it connected to PPGNHAIK?
Kaleido Health is an independent entity where CEO Rebecca Gibron serves as board chair. The exact nature of the partnership is not publicly detailed, but the board overlap suggests strategic coordination in reproductive health delivery or adjacent services, creating a potential pathway for mission-aligned programmatic investing outside the endowment itself.
Does PPGNHAIK maintain any co-investor relationships with peer nonprofits?
The ACLU functions as a consistent co-investor in litigation, not in the endowment portfolio. In the investment context, donor relationships with the Peierls Foundation and BNY Mellon Charitable Gift Fund provide connective tissue to progressive philanthropic capital networks, but no formal co-investment vehicles with peer nonprofits are disclosed.
How does the multi-state clinic footprint affect capital allocation?
Operating health centers across Alaska, Hawai'i, Idaho, Indiana, Kentucky, and Washington means PPGNHAIK faces six distinct regulatory environments and political risk profiles. The endowment functions as a geographic diversification buffer — when one state's political climate restricts operations or reduces patient volume, the portfolio can subsidize losses and fund legal challenges in that jurisdiction.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: